T1	Premise 57 202	A 43-year-old woman with a levonorgestrel intrauterine device who consults for lack of rest at night with the appearance of heat and palpitations
T2	Premise 204 391	In the analytical analysis highlights free T4 10.5 pmol/L (9-19), thyrotropin 2.1 mIU/L (0.30-5.00), FSH 95.6 IU/L (1.38-16.7), LH 21 IU/L (2.4-9.3), estradiol < 0.07 nmol/L (0.07 - 1.14)
T3	Claim 436 451	Benzodiazepines
T4	Claim 456 473	Vaginal estrogens
T5	Claim 478 531	Oral estrogens and progestogens in continuous regimen
T6	Claim 536 581	Transdermal estrogens in a continuous regimen
T7	Claim 608 663	The hormonal profile we are told is in menopausal range
T8	Premise 665 686	FSH >20; estradiol <5
R1	Support Ent1:T8 Ent2:T7	
T9	Premise 692 735	the patient has systemic vasomotor symptoms
R2	Support Ent1:T9 Ent2:T7	
T10	Claim 737 809	Therefore, it would be more appropriate to administer systemic estrogens
T11	Marker 737 746	Therefore
R3	Support Ent1:T7 Ent2:T10	
R4	Support Ent1:T10 Ent2:T6	
T12	Premise 811 888	To compensate, she already has a local uterine progestin (levonorgestrel IUD)
T13	Treatment 436 451	Benzodiazepines
T14	Treatment 456 473	Vaginal estrogens
T15	Treatment 478 531	Oral estrogens and progestogens in continuous regimen
T16	Treatment 536 581	Transdermal estrogens in a continuous regimen
T17	Treatment 791 809	systemic estrogens
T18	Treatment 844 888	local uterine progestin (levonorgestrel IUD)
